Resources

Our goal is to transparently share knowledge, and in our work we review many scientific publications. Here’s a snapshot of top articles and videos, as well as some introductory material if you are new to the field. Enjoy!

Theranostics

Video Spotlights

Targeted Therapies

Check out this great video about Targeted Therapies in Cancer Treatment

177Lu-DOTA-octreotate

Application of radiolabeled peptides for targeted therapy; 177Lu-DOTA-octreotate emits gamma and beta particle radiation, the peptide molecules bind somatostatin receptors on tumor cells and can be applied for both tumor imaging and radionuclide therapy.

Targeted Alpha Therapies

How does Targeted Alpha therapy work? Check out this video to find out.

What is Targeted Therapy?

Insider info:

Lutetium

There’s much to see here. We are sharing “hot”, recent publications in the field of theranostics. So, take your time, look around, and learn. We hope you enjoy our library. More to come!

Lutetium Targeted Therapies

Current Status of 177 Lu-PSMA Targeted Therapies and Where Will We Be In the Near Future

ESMO Preliminary Results

ESMO 2019: Preliminary Results of a Phase I/II Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive mCRPC

Lutetium plus Idronoxil

Phase I/II Trial of Lutetium-177–PSMA-617 Plus Idronoxil in Metastatic Castration-Resistant Prostate Cancer

Radioligand Treatment

PSMA PET During Lu-177–PSMA Radioligand Therapy May Help Guide Treatment

Metastatic Prostate Cancer

Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer

Insider info:

Actinium

Advanced Prostate Cancer: 225-Ac-PSMA-618 Treatment

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

Tandem Therapy of Prostate Cancer

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

Safety and Efficacy

Safety and Efficacy of Ac-225-PSMA-617 in mCRPC after Failure of Lu-177-PSMA

Insider info:

Iodine

Iodine Targeting

Iodine Symporter Targeting with 124I/131I Theranostics

Neuroblastoma Theranostics

¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications

Neuroblastoma Imaging

MIBG in Neuroblastoma Diagnostic Imaging and Therapy.

Insider info:

Zirconium

Zirconium as tool in Imaging

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients

Zirconium in Oncology

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Zirconium Radiochemistry

89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry

Learning:

What are Monoclonal Antibodies?

Thank you for visiting our Library.

Knowledge is important in our business, we strive for the highest level of excellence in our business, service, and competencies. Feel free to reach out if you want more information.

Chat with the experts.

We’d love to understand your needs and help your patients.